Abstracts tagged "Classification criteria and myositis"

Abstract Number: 2296 • 2018 ACR/ARHP Annual Meeting
Novel Classification of Idiopathic Inflammatory Myopathies Based on Distinctive Features and Autoantibodies: Analysis of 67 Korean Patients
Sang Wan Chung¹, Su-Jin Yoo², Seong-Wook Kang³, In-Seol Yoo³, Seung-Cheol Shim³, Mihye Kwon⁴, Chung-Il Joung⁴, Jinhyun Kim⁵, Seung-Jae Hong¹ and Yeon-Ah Lee⁶, ¹Division of Rheumatology, Department of Internal Medicine, Kyung Hee University Hospital, Seoul, Korea, Republic of (South), ²Departmen of Internal medicine, Chungnam National University School of Medicine, Daejeon, Korea, Republic of (South), ³Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea, Republic of (South), ⁴Department of Internal Medicine, Konyang University hospital, Daejeon, Korea, Republic of (South), ⁵Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea, Republic of (South), ⁶Rheumatology, Kyung Hee University Hospital, Seoul, Korea, Republic of (South)
Novel Classification Of Idiopathic Inflammatory Myopathies Based On Distinctive Features And Autoantibodies: Analysis Of 67 Korean PatientsBackground/Purpose: Since Bohan and Peter first described their diagnostic…
Abstract Number: 2297 • 2018 ACR/ARHP Annual Meeting
Performance of the New EULAR/Acr Classification Criteria for Idiopathic Inflammatory Myopathies (IIM) in a Large Monocentric IIM Cohort
Simone Barsotti^1,2, Valérie Leclair^3,4, Antonella Notarnicola^5,6, Luise Ekholm^3,4, Lara Dani^3,4, Maryam Dastmalchi^3,4 and Ingrid E. Lundberg⁶, ¹Rheumatology Unit, University of Pisa, Pisa, Italy, ²Department of Medical Biotechnologies, University of Siena, Siena, Italy, ³Department of Medicine, Division of rheumatology, Solna, Sweden, ⁴Kaolinska Institutet and Karolinska University Hospital, Stockholm, Sweden, ⁵Department of Medicine, Rheumatology Unit, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden, ⁶Department of Medicine, Division of Rheumatology, Karolinska Institutet, Stockholm, Sweden
Background/Purpose: Patients with IIM have been classified mainly according to Bohan and Peter (B&P) criteria, proposed in 1975. In 2017 the new EULAR/ACR criteria were…
Abstract Number: 753 • 2012 ACR/ARHP Annual Meeting
Progress Report On Development of Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies
Anna Tjärnlund¹, Matteo Bottai², Lisa G. Rider³, Victoria P. Werth⁴, Clarissa A. Pilkington⁵, Marianne de Visser⁶, Lars Alfredsson⁷, Anthony A Amato⁸, Richard J. Barohn⁹, Matthew H. Liang¹⁰, Jasvinder A. Singh¹¹, Frederick W. Miller³, Ingrid E. Lundberg¹² and the International Myositis Classification Criteria Project¹³, ¹Rheumatology Unit, Department of Medicine, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Stockholm, Sweden, ²Institute for Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, Stockholm, Sweden, ³Environmental Autoimmunity Group, NIEHS, NIH, Bethesda, MD, ⁴Department of Dermatology, Veteran Affairs Medical Center, Philadelphia, PA, ⁵Department of Rheumatology, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom, ⁶Department of Neurology, Academic Medical Centre, Amsterdam, Netherlands, Amsterdam, Netherlands, ⁷Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, ⁸Brigham and Women's Hospital and Harvard Medical School, Boston, MA, ⁹Department of Neurology, University of Kansas Medical Center, Kansas City, USA, Kansas City, MO, ¹⁰Dept Med/Rheum/Immun/PBB-B3, Brigham & Womens Hospital, Boston, MA, ¹¹Department of Medicine, University of Alabama, Tuscaloosa, AL, ¹²Rheumatology Unit, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden, ¹³Stockholm
Background/Purpose: In patients with idiopathic inflammatory myopathies (IIM) persisting muscle impairment after treatment underscores the need for improved management. Inadequate classification criteria for IIM are…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].